| Original language | English (US) |
|---|---|
| Pages (from-to) | S28-S29 |
| Journal | European Journal of Cancer |
| Volume | 174 |
| DOIs | |
| State | Published - Oct 2022 |
Phase I dose-escalation study of the pan-PI3 K inhibitor copanlisib in children and adolescents with relapsed/refractory solid tumors
- M. Macy
- , T. Cash
- , N. Pinto
- , J. G. Pressey
- , L. Szalontay
- , W. L. Furman
- , A. Bukowinski
- , J. H. Foster
- , G. K. Friedman
- , J. HaDuong
- , E. Fox
- , B. J. Weigel
- , J. Grevel
- , F. Huang
- , C. Phelps
- , B. H. Childs
- , J. Chung
- , S. Chaturvedi
- , A. Schulz
- , S. G. DuBois
Research output: Contribution to journal › Article › peer-review
4
Scopus
citations